A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis.
about
Topical tacrolimus for atopic dermatitisCurrent Management of Pediatric Vitiligo.Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.A systematic review of the safety of topical therapies for atopic dermatitis.Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.Clinical pearls from atopic dermatitis and its infectious complications.Skin absorption through atopic dermatitis skin: a systematic review.Tacrolimus ointment in the management of atopic dermatitis.Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies.Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National HealTopical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis.Atopic dermatitis: a review of topical nonsteroid therapy.Tacrolimus: a new option in therapy-resistant chronic external otitis.Re: risk of malignancy and systemic absorption after application of topical tacrolimus in oral lichen planus.
P2860
Q24186624-E07B5420-F462-4B5B-96DA-BD048410C3B3Q34478386-20B657AE-310A-461A-AE35-13A159067357Q36153370-C0F9AFA5-F2C4-486D-8AA9-C67D165BDE3DQ36222741-3A07C606-D060-4F30-B46E-45AA80322B5AQ36708358-842988BB-B845-4D1C-AB27-9A2417155DB2Q36861654-64355D94-BC6E-40FC-9300-FCEB971C3AC4Q36940038-9B7527AB-A535-4342-9C6C-F02BFB4491A3Q37861867-F9815E22-D905-4C4F-A3D5-E42EA09DDC20Q38203586-9E46A61B-3440-4ABF-8618-2C93412825A7Q38957449-B8057503-33EF-461E-BF9E-080CA27386D4Q42081579-6F423E9A-8A53-49A8-9A50-D2E3B572EB05Q43200436-FBCC97B3-0EA8-4C84-BED1-D822303F6207Q44513075-329953EA-ED84-4778-85AC-0B5EFFC75EDDQ46718321-6A48A62D-B401-4137-9489-8DD1B013A510Q46868092-9E48A5AA-E6E7-453B-8E11-77B339160DB4Q52597622-0849F764-B265-41AE-81DE-333B775C2984Q52926520-67D1C0A1-A3AC-48A8-95BC-A0A9605474F0Q53754576-2B793031-7949-420A-9FA1-00ECD9A24DE4
P2860
A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A multicenter study of the pha ...... ildren with atopic dermatitis.
@en
A multicenter study of the pha ...... ildren with atopic dermatitis.
@nl
type
label
A multicenter study of the pha ...... ildren with atopic dermatitis.
@en
A multicenter study of the pha ...... ildren with atopic dermatitis.
@nl
prefLabel
A multicenter study of the pha ...... ildren with atopic dermatitis.
@en
A multicenter study of the pha ...... ildren with atopic dermatitis.
@nl
P2093
P1476
A multicenter study of the pha ...... hildren with atopic dermatitis
@en
P2093
Adrian Green
Andris Rubins
Augustín Alomar
Claire Foster
John Bourke
John Harper
Karina Jackson
Nasrullah Undre
Paul Stevenson
Sanita Zigure
P304
P356
10.1111/J.0022-202X.2005.23644.X
P407
P577
2005-04-01T00:00:00Z
P6179
1044095659